Delivery Order SPE2DB22D3501-SPE2DB25FWF49
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of TESTOSTERONE 1% (25MG/2.5G) PK 2.5GM, a pharmaceutical product. The contract has a ceiling value of $1,296.00 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TESTOSTERONE 1% (25MG/2.5G) PK 2.5GM, a pharmaceutical product, with a ceiling value of $1,621.28 and a period of performance through July 16, 2025. The contract is a Firm Fixed Price delivery order, with no set-aside designation, indicating open competition....
- This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,117.37, is for the delivery of 4563347537 ! TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM. The contract has a completion date of January 18, 2024 and is a Firm Fixed Price Delivery Order. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999...
- This federal contract award is for the delivery of TESTOSTERONE 1% (25MG/2.5G) PK UD 2.5GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $3,673.92. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM, a pharmaceutical product, with a ceiling value of $1,186.56 and a period of performance through December 12, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,578.49 firm fixed-price delivery order is for the supply of 4568196920 - Testosterone 1% (25mg/2.5g) PK 2.5gm pharmaceutical products. The contract has an ultimate completion date of May 12, 2025. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This award is associated...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,057.91 firm fixed-price delivery order is for the supply of Testosterone 1% (50 mg/5 g) prescription medication. The contract has a ceiling value of $1,057.91 and a completion date of March 12, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a larger $999,999,999 Indefinite...
- This is a $1,245.10 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4568324641 - TESTOSTERONE 1% (25MG/2.5G) PK 2.5GM pharmaceutical products. It has an ultimate completion date of May 22, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,266.96, is for the delivery of testosterone 1% (25mg/2.5g) pharmaceutical product. The contract has a completion date of February 19, 2025 and is a Firm Fixed Price Delivery Order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a for-profit organization and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, with a ceiling value of $1,894.21, is for the supply of testosterone 1% (25mg/2.5g) pharmaceutical products. The contract has a completion date of May 15, 2024 and is a firm-fixed-price contract. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWF49Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of TESTOSTERONE 1% (25MG/2.5G) pharmaceutical product, with a ceiling value of $1,939.72 and a completion date of July 1, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and this award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by the company with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract positions Amerisourcebergen Drug Corp as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/30/25 |